CHORIONIC GONADOTROPIN (chorionic gonadotropin, human)
HYPOGONADOTROPIC HYPOGONADISM·+2
APP PHARMACEUTI
Indication
Hypogonadotropic hypogonadism
Hypogonadotropic hypogonadism, also known as secondary or central hypogonadism, is an endocrine disorder characterized by impaired gonadal function resulting from deficient stimulation by the hypothalamic-pituitary-gonadal axis. Read more about Hypogonadotropic hypogonadism
13 drugs 8 manufacturers
Drugs that treat it
Common Hypogonadotropic hypogonadism therapies.
PREGNYL (chorionic gonadotropin, human)
HYPOGONADOTROPIC HYPOGONADISM·+2
ORGANON PHARM.
FOLLISTIM AQ (follitropin beta,recombinant)
HYPOGONADOTROPIC HYPOGONADISM·+2
ORGANON PHARM.
GONAL-F RFF REDI-JECT (follitropin alfa, recombinant)
FOLLICLE-STIMULATING HORMONE (FSH)·HYPOGONADOTROPIC HYPOGONADISM·+2
EMD SERONO, INC
GONAL-F (follitropin alfa, recombinant)
FOLLICLE-STIMULATING HORMONE (FSH)·HYPOGONADOTROPIC HYPOGONADISM·+2
EMD SERONO, INC
NOVAREL (chorionic gonadotropin, human)
HUMAN CHORIONIC GONADOTROPIN (HCG)·HYPOGONADOTROPIC HYPOGONADISM·+2
FERRING PH INC
GONAL-F RFF REDI-JECT (follitropin alfa, recombinant)
FOLLICLE-STIMULATING HORMONE (FSH)·HYPOGONADOTROPIC HYPOGONADISM·+2
EMD SERONO, INC
CHORIONIC GONADOTROPIN (chorionic gonadotropin, human)
HUMAN CHORIONIC GONADOTROPIN (HCG)·HYPOGONADOTROPIC HYPOGONADISM·+2
FRESENIUS KABI
PREGNYL (chorionic gonadotropin, human)
HUMAN CHORIONIC GONADOTROPIN (HCG)·HYPOGONADOTROPIC HYPOGONADISM·+2
Merck Sharp & Dohme
Filter & compare in the drug finder →Opens the drug finder with Hypogonadotropic hypogonadism preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypogonadotropic hypogonadism, also known as secondary or central hypogonadism, is an endocrine disorder characterized by impaired gonadal function resulting from deficient stimulation by the hypothalamic-pituitary-gonadal axis.
It affects both male and female pediatric and adult populations, stemming from congenital defects, genetic anomalies such as Kallmann syndrome, or acquired structural, functional, or systemic insults to the hypothalamus or anterior pituitary gland.
Pathophysiologically, insufficient secretion of gonadotropin-releasing hormone, luteinizing hormone, or follicle-stimulating hormone leads to abnormally low levels of circulating sex steroids.
Clinically, this manifests as delayed, arrested, or absent puberty in adolescents, and infertility, sexual dysfunction, decreased bone mineral density, and loss of secondary sexual characteristics in adults.
- nih.gov
Hypogonadotropic hypogonadism, also known as secondary or central hypogonadism, is an endocrine disorder characterized by impaired gonadal function resulting from deficient stimulation by the hypothalamic-pituitary-gonadal axis It affects both male and female pediatric and adult populations, stemming from congenital defects, genetic anomalies such as Kallmann syndrome, or acquired structural, functional, or systemic insults to the hypothalamus or anterior pituitary gland Pathophysiologically, in...
- wikipedia.org
Hypogonadotropic hypogonadism, also known as secondary or central hypogonadism, is an endocrine disorder characterized by impaired gonadal function resulting from deficient stimulation by the hypothalamic-pituitary-gonadal axis Pathophysiologically, insufficient secretion of gonadotropin-releasing hormone, luteinizing hormone, or follicle-stimulating hormone leads to abnormally low levels of circulating sex steroids
- medihelpapp.com
Hypogonadotropic hypogonadism, also known as secondary or central hypogonadism, is an endocrine disorder characterized by impaired gonadal function resulting from deficient stimulation by the hypothalamic-pituitary-gonadal axis
- medlineplus.gov
It affects both male and female pediatric and adult populations, stemming from congenital defects, genetic anomalies such as Kallmann syndrome, or acquired structural, functional, or systemic insults to the hypothalamus or anterior pituitary gland Pathophysiologically, insufficient secretion of gonadotropin-releasing hormone, luteinizing hormone, or follicle-stimulating hormone leads to abnormally low levels of circulating sex steroids Clinically, this manifests as delayed, arrested, or absent p...
- mayoclinic.org
Clinically, this manifests as delayed, arrested, or absent puberty in adolescents, and infertility, sexual dysfunction, decreased bone mineral density, and loss of secondary sexual characteristics in adults
- medlineplus.gov
Clinically, this manifests as delayed, arrested, or absent puberty in adolescents, and infertility, sexual dysfunction, decreased bone mineral density, and loss of secondary sexual characteristics in adults
Personalize your experience
Follow Hypogonadotropic hypogonadism and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.